Abstract
What can be expected from combination therapy? What is the goal of combination therapy? What criteria allow drug selection? Is combination therapy regularly used for controlling rheumatoid arthritis? What combination therapies have been assessed with clinical trials? What is the contribution of prolonged combination therapy? Conclusion
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / drug therapy*
-
Clinical Trials as Topic
-
Drug Therapy, Combination
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Infliximab
-
Methotrexate / therapeutic use
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Immunosuppressive Agents
-
Infliximab
-
Methotrexate